课题基金 / 基金详情

Molecular Control of Plasmacytoid Dendritic Cell Development and Function

Molecular Control of Plasmacytoid Dendritic Cell Development and Function
浆细胞样树突状细胞发育和功能的分子控制
批准号:
10583989
负责人:
Boris Reizis
金额:
$61.79万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-01 至 2028-07-31

项目摘要

项目成果

Boris Reizis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Plasmacytoid dendritic cells (pDCs) rapidly secrete type I interferon (interferon α/β, IFN) in response to virus- derived nucleic acids, facilitating both innate and adaptive antiviral responses. Conversely, aberrant IFN production by pDCs is associated with autoimmune diseases, establishing pDCs as important emerging therapeutic targets. The overall goal of this project is to elucidate the molecular control of pDCs lineage, including its development, homeostasis and function in various immune responses. In the previous award cycles, we have identified E protein transcription factor TCF4 (E2-2) and several other factors as important regulators of pDC development. The proposed work will build upon these findings to address major unanswered questions in pDC biology. In Aim 1, we will use high-dimensional single-cell analysis methods to characterize the stage and regulation of pDC lineage specification, as well as the functional heterogeneity of mature pDCs. In Aim 2, we will use genetic approaches to dissect transcriptional control and regulation of the unique IFN-producing capacity of pDCs. In Aim 3, we will explore the mechanism of virus recognition and IFN production by pDCs in vivo. Collectively, the proposed studies should yield a comprehensive molecular view of pDC development and function, paving the way for therapeutic approaches focused on this cell type. RELEVANCE (See instructions): Plasmacytoid dendritic cells (pDCs) play an important role in immune responses to infection and in autoimmunity, and therefore represent attractive targets for novel immunoterapies. The proposed work aims to build a comprehensive molecular view of pDC development and function, paving the way for pDCfocused translational approaches in human diseases.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/nri3477
发表时间: 2013-08
期刊: Nature reviews. Immunology
影响因子: --
作者: []
通讯作者:
DOI: 10.1146/annurev-immunol-031210-101345
发表时间: 2011
期刊: Annual review of immunology
影响因子: 29.7
作者: [Reizis B, Bunin A, Ghosh HS, Lewis KL, Sisirak V]
通讯作者: Sisirak V
DOI: 10.1084/jem.20180136
发表时间: 2018-11-05
期刊: The Journal of experimental medicine
影响因子: --
作者: [Upadhaya S, Sawai CM, Papalexi E, Rashidfarrokhi A, Jang G, Chattopadhyay P, Satija R, Reizis B]
通讯作者: Reizis B
DOI: 10.3389/fimmu.2018.02475
发表时间: 2018
期刊: Frontiers in immunology
影响因子: 7.3
作者: [Sawai CM, Serpas L, Neto AG, Jang G, Rashidfarrokhi A, Kolbeck R, Sanjuan MA, Reizis B, Sisirak V]
通讯作者: Sisirak V
10
    Chromatin architecture as a regulator of dendritic cell function
    A novel regulator of extracellular nucleic acid sensing
    A novel regulator of dendritic cell differentiation
    Novel genetic tools for the analysis of plasmacytoid dendritic cell function in vivo
    海外基金